Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.132 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.132 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.132 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.83NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.83NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCSNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18863US
XCSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCSNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16953.8China
GA.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CR.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KB.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KB.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used